Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 15, Number 5—May 2009
Research

Cross-Border Dissemination of Methicillin-Resistant Staphylococcus aureus, Euregio Meuse-Rhin Region

Ruud H. DeurenbergComments to Author , Eric Nulens, Havard Valvatne, Silvie Sebastian, Christel Driessen, Jos Craeghs, Els De Brauwer, Bernhard Heising, Yvette J. Kraat, Joachim Riebe, Frans S. Stals, Thera A. Trienekens, Jacques Scheres, Alexander W. Friedrich, Frank H. Van Tiel, Patrick S. Beisser, and Ellen E. Stobberingh
Author affiliations: University Hospital Maastricht, Maastricht, the Netherlands (R.H. Deurenberg, H. Valvatne, S. Sebastian, C. Driessen, J. Scheres, F.H. van Tiel, P.S. Beisser, E.E. Stobberingh); General Hospital Sint-Jan, Brugge, Belgium (E. Nulens); General Hospital Vesalius, Tongeren, Belgium (J. Craeghs); Atrium Medical Center, Heerlen, the Netherlands (E. De Brauwer); General Hospital Düren, Düren, Germany (B. Heising); Orbis Medical and Care Center, Sittard, the Netherlands (Y.J. Kraat); Laboratory Aachen, Aachen, Germany (J. Riebe); Laurentius Hospital, Roermond, the Netherlands (F.S. Stals); VieCuri Medical Center, Venlo, the Netherlands (T.A. Trienekens); University of Münster, Münster, Germany (A.W. Friedrich)

Main Article

Table 1

Non–β-lactam antimicrobial drug resistance patterns of 257 MRSA isolates in the Euregio Meuse-Rhin region, July 2005–April 2006*

Country No. isolates No. (%) resistant MRSA isolates
CIP MXF CLI GEN CLR SXT TET RIF MUP FUC
Belgium 44 44 (100) 43 (98) 5 (11) 2 (5) 24 (55) 0 4 (9) 0 4 (9) 0
Germany 92 89 (97) 89 (97) 78 (85) 5 (5) 83 (90) 0 3 (3) 2 (2) 1 (1) 1 (1)
The Netherlands 121 84 (69) 79 (65) 76 (63) 11 (9) 93 (77) 3 (2) 22 (18) 0 8 (7) 1 (1)
Total 257 217 (84) 211 (82) 159 (62) 18 (7) 200 (78) 3 (1) 29 (12) 2 (1) 13 (5) 2 (1)

*MRSA, methicillin-resistant Staphylococcus aureus; CIP, ciprofloxacin; MXF, moxifloxacin; CLI, clindamycin; GEN, gentamicin; CLR, clarithromycin; SXT, trimethoprim/sulfamethoxazole; TET, tetracycline; RIF, rifampin; MUP, mupirocin; FUC, fucidic acid. No isolates showed resistance to linezolid, vancomycin, or teicoplanin.

Main Article

Page created: December 16, 2010
Page updated: December 16, 2010
Page reviewed: December 16, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external